|
1
|
Faris JE and Zhu AX: Targeted therapy for
biliary tract cancers. J Hepatobiliary Pancreat Sci. 19:326–336.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Valle J, Wasan H, Palmer DH, et al:
Cisplatin plus gemcitabine versus gemcitabine for biliary tract
cancer. N Engl J Med. 362:1273–1281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gores GJ: Cholangiocarcinoma: current
concepts and insights. Hepatology. 37:961–969. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khan SA, Davidson BR, Goldin RD, et al:
Guidelines for the diagnosis and treatment of cholangiocarcinoma:
an update. Gut. 61:1657–1669. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rustagi T and Dasanu CA: Risk factors for
gallbladder cancer and cholangiocarcinoma: similarities,
differences and updates. J Gastrointest Cancer. 43:137–147. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kubo S, Nakanuma Y, Takemura S, et al:
Case series of 17 patients with cholangiocarcinoma among young
adult workers of a printing company in Japan. J Hepatobiliary
Pancreat Sci. Jan 13–2014.(Epub ahead of print).
|
|
7
|
Kumagai S, Kurumatani N, Arimoto A and
Ichihara G: Cholangiocarcinoma among offset colour proof-printing
workers exposed to 1,2-dichloropropane and/or dichloromethane.
Occup Environ Med. 70:508–510. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meng F, Henson R, Lang M, et al:
Involvement of human micro-RNA in growth and response to
chemotherapy in human cholangiocarcinoma cell lines.
Gastroenterology. 130:2113–2129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mott JL, Kobayashi S, Bronk SF and Gores
GJ: mir-29 regulates Mcl-1 protein expression and apoptosis.
Oncogene. 26:6133–6140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pignochino Y, Sarotto I, Peraldo-Neia C,
et al: Targeting EGFR/HER2 pathways enhances the antiproliferative
effect of gemcitabine in biliary tract and gallbladder carcinomas.
BMC Cancer. 10:6312010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Saito S, Ghosh M, Morita K, Hirano T, Miwa
M and Todoroki T: The genetic differences between gallbladder and
bile duct cancer cell lines. Oncol Rep. 16:949–956. 2006.PubMed/NCBI
|
|
12
|
Selaru FM, Olaru AV, Kan T, et al:
MicroRNA-21 is overexpressed in human cholangiocarcinoma and
regulates programmed cell death 4 and tissue inhibitor of
metalloproteinase 3. Hepatology. 49:1595–1601. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Watanabe M, Chigusa M, Takahashi H,
Nakamura J, Tanaka H and Ohno T: High level of CA19-9, CA50, and
CEA-producible human cholangiocarcinoma cell line changes in the
secretion ratios in vitro or in vivo. In Vitro Cell Dev Biol Anim.
36:104–109. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mizuno S and Glowacki J: Three-dimensional
composite of demineralized bone powder and collagen for in vitro
analysis of chondroinduction of human dermal fibroblasts.
Biomaterials. 17:1819–1825. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mizuno S and Glowacki J: Chondroinduction
of human dermal fibroblasts by demineralized bone in
three-dimensional culture. Exp Cell Res. 227:89–97. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yates KE, Mizuno S and Glowacki J: Early
shifts in gene expression during chondroinduction of human dermal
fibroblasts. Exp Cell Res. 265:203–211. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mizuno S, Allemann F and Glowacki J:
Effects of medium perfusion on matrix production by bovine
chondrocytes in three-dimensional collagen sponges. J Biomed Mater
Res. 56:368–375. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Manome Y, Saeki N, Yoshinaga H, Watanabe M
and Mizuno S: A culture device demonstrates that hydrostatic
pressure increases mRNA of RGS5 in neuroblastoma and CHC1-L in
lymphocytic cells. Cells Tissues Organs. 174:155–161. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mizuno S, Tateishi T, Ushida T and
Glowacki J: Hydrostatic fluid pressure enhances matrix synthesis
and accumulation by bovine chondrocytes in three-dimensional
culture. J Cell Physiol. 193:319–327. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mizuno S and Glowacki J: Low oxygen
tension enhances chondroinduction by demineralized bone matrix in
human dermal fibroblasts in vitro. Cells Tissues Organs.
180:151–158. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Manome Y, Mizuno S, Akiyama N, et al:
Three-dimensional cell culture of glioma and morphological
comparison of four different human cell lines. Anticancer Res.
30:383–389. 2010.PubMed/NCBI
|
|
22
|
Pampaloni F, Reynaud EG and Stelzer EH:
The third dimension bridges the gap between cell culture and live
tissue. Nat Rev Mol Cell Biol. 8:839–845. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Noel MS and Hezel AF: New and emerging
treatment options for biliary tract cancer. Onco Targets Ther.
6:1545–1552. 2013.PubMed/NCBI
|
|
24
|
de Marsh RW, Alonzo M, Bajaj S, et al:
Comprehensive review of the diagnosis and treatment of biliary
tract cancer 2012. Part I: diagnosis-clinical staging and
pathology. J Surg Oncol. 106:332–338. 2012.PubMed/NCBI
|
|
25
|
Patel T: Cholangiocarcinoma. Nat Clin
Pract Gastroenterol Hepatol. 3:33–42. 2006. View Article : Google Scholar
|
|
26
|
Farley DR, Weaver AL and Nagorney DM:
‘Natural history’ of unresected cholangiocarcinoma: patient outcome
after noncurative intervention. Mayo Clin Proc. 70:425–429.
1995.
|
|
27
|
Jarnagin WR and Shoup M: Surgical
management of cholangiocarcinoma. Semin Liver Dis. 24:189–199.
2004. View Article : Google Scholar
|
|
28
|
Malhi H and Gores GJ: Review article: the
modern diagnosis and therapy of cholangiocarcinoma. Aliment
Pharmacol Ther. 23:1287–1296. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Henson DE, Albores-Saavedra J and Corle D:
Carcinoma of the extrahepatic bile ducts. Histologic types, stage
of disease, grade, and survival rates. Cancer. 70:1498–1501. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ben-Menachem T: Risk factors for
cholangiocarcinoma. Eur J Gastroenterol Hepatol. 19:615–617. 2007.
View Article : Google Scholar
|
|
31
|
Lazaridis KN and Gores GJ:
Cholangiocarcinoma. Gastroenterology. 128:1655–1667. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kleinman HK and Jacob K: Invasion assays.
Curr Protoc Cell Biol. Chapter 12(Unit 12.2)2001.
|
|
33
|
Kleinman HK and Martin GR: Matrigel:
basement membrane matrix with biological activity. Semin Cancer
Biol. 15:378–386. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Marques MM, Martins MD and França CM:
Effect of Matrigel on adenoid cystic carcinoma cell line
differentiation. Int J Exp Pathol. 87:405–410. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
de Ridder L, Cornelissen M and de Ridder
D: Autologous spheroid culture: a screening tool for human brain
tumour invasion. Crit Rev Oncol Hematol. 36:107–122.
2000.PubMed/NCBI
|
|
36
|
Kunz-Schughart LA, Kreutz M and Knuechel
R: Multicellular spheroids: a three-dimensional in vitro culture
system to study tumour biology. Int J Exp Pathol. 79:1–23. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kleinman HK, Philp D and Hoffman MP: Role
of the extracellular matrix in morphogenesis. Curr Opin Biotechnol.
14:526–532. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Manome Y, Furuhata H, Hashimoto A, et al:
Application of therapeutic insonation to malignant glioma cells and
facilitation by echo-contrast microbubbles of levovist. Anticancer
Res. 29:235–242. 2009.PubMed/NCBI
|
